FDA Approves World's First mRNA-Based Flu Vaccine

The U.S. Food and Drug Administration has approved the world's first mRNA-based flu vaccine, intended for people 50 and older. This approval marks a significant step in illness prevention, as trials showed the vaccine to be more effective than standard flu shots.